To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.
IXICO
2 followers
Oxford Quantum Circuits
7 followers
REVOLUTION Medicines
19 followers
Freenome
10 followers
Halozyme Therapeutics
10 followers
BillionToOne
8 followers
Summit Therapeutics
8 followers
Altos Labs
7 followers
Institution of Chemical Engineers (IChemE)
1 follower
Dyne Therapeutics
6 followers
Beta Bionics
5 followers
Biosynth
3 followers